Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Winzent-Oonk, Shelby
11  Ergebnisse:
Personensuche X
?
1

NURS-23. THE ROLE OF THE ADVANCED PRACTICE PROVIDER IN THE ..:

Hemenway, Molly S ; Winzent-Oonk, Shelby
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
2

PALC-03. MEDICAL AID IN DYING: EXPERIENCE IN THE CENTER FOR..:

Winzent-Oonk, Shelby ; Vallejos, Chelsea ; Hemenway, Molly..
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
3

CP-12. PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL ..:

Dorris, Kathleen ; Mettetal, Ashley ; Hemenway, Molly...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
?
4

OTHR-03. Oxaliplatin as a hearing-sparing alternative to ca..:

Cho, Soohee ; Miller, Kristen ; Rowley, Jacqueline...
Neuro-Oncology.  24 (2022)  Supplement_1 - p. i147-i147 , 2022
Link: https://doi.org/10.1093/..
 
?
5

EPID-06. Transfusion related iron overload in pediatric pat..:

Winzent-Oonk, Shelby ; Winters, Amanda ; Pounds, Aneisia...
Neuro-Oncology.  24 (2022)  Supplement_1 - p. i47-i48 , 2022
Link: https://doi.org/10.1093/..
 
?
6

RARE-32. Phase 0 and feasibility single-institution clinica..:

Dorris, Kathleen ; Mettetal, Ashley ; Dahl, Nathan...
Neuro-Oncology.  24 (2022)  Supplement_1 - p. i17-i17 , 2022
Link: https://doi.org/10.1093/..
 
?
7

RARE-32. Phase 0 and feasibility single-institution clinica..:

Dorris, Kathleen ; Mettetal, Ashley ; Dahl, Nathan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165090/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

SWK-10. Survivorship: Education, Clinical Guidelines, and T..:

Hemenway, Molly ; Dorris, Kathleen ; Foreman, Nicholas...
Neuro-Oncology.  24 (2022)  Supplement_1 - p. i182-i183 , 2022
Link: https://doi.org/10.1093/..
 
?
9

MODL-01. SAFETY IN CONCOMITANT USE OF MEK AND BRAF INHIBITO..:

Winzent, Shelby ; Sabus, Ashley ; Hemenway, Molly..
Neuro-Oncology.  22 (2020)  Supplement_3 - p. iii411-iii412 , 2020
Link: https://doi.org/10.1093/..
 
?
10

OTHR-16. CONCURRENT USE OF APREPITANT AND IFOSFAMIDE IN PED..:

Winzent, Shelby ; Dahl, Nathan ; Hemenway, Molly..
Neuro-Oncology.  22 (2020)  Supplement_3 - p. iii424-iii424 , 2020
Link: https://doi.org/10.1093/..
 
?
11

DDEL-06. DRUG INTERACTION BETWEEN EVEROLIMUS AND CANNABIDIO..:

Sabus, Ashley ; Winzent, Shelby ; Hemenway, Molly..
Neuro-Oncology.  22 (2020)  Supplement_3 - p. iii284-iii284 , 2020
Link: https://doi.org/10.1093/..
 
1-11